Molecular Targeting of Acid Ceramidase in Glioblastoma: A Review of Its Role, Potential Treatment, and Challenges
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Targeting of Acid Ceramidase in Glioblastoma: A Review of Its Role, Potential Treatment, and Challenges
Authors
Keywords
-
Journal
Pharmaceutics
Volume 10, Issue 2, Pages 45
Publisher
MDPI AG
Online
2018-04-11
DOI
10.3390/pharmaceutics10020045
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα
- (2018) Helen S. Vethakanraj et al. ANTI-CANCER DRUGS
- The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia
- (2017) Su-Fern Tan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- HCFU inhibits cervical cancer cells growth and metastasis by inactivating Wnt/β-catenin pathway
- (2017) Ping Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Adult Glioblastoma
- (2017) Brian M. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacophore Identification and Scaffold Exploration to Discover Novel, Potent, and Chemically Stable Inhibitors of Acid Ceramidase in Melanoma Cells
- (2017) Jose Antonio Ortega et al. JOURNAL OF MEDICINAL CHEMISTRY
- A systematic review of perioperative seizure prophylaxis during brain tumor resection: the case for a multicenter randomized clinical trial
- (2017) Vyshak Chandra et al. Neurosurgical Focus
- Acid ceramidase confers radioresistance to glioblastoma cells
- (2017) Ninh B. Doan et al. ONCOLOGY REPORTS
- Acid ceramidase is a novel drug target for pediatric brain tumors
- (2017) Ninh B. Doan et al. Oncotarget
- Acid ceramidase and its inhibitors: a de novo drug target and a new class of drugs for killing glioblastoma cancer stem cells with high efficiency
- (2017) Ninh B. Doan et al. Oncotarget
- Anticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidase
- (2017) Aiping Bai et al. PLoS One
- Complete Acid Ceramidase ablation prevents cancer-initiating cell formation in melanoma cells
- (2017) Michele Lai et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- The role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: A systematic review
- (2016) Alireza Mansouri et al. CANCER
- Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
- (2016) Jun-Rui Chen et al. MEDICINE
- Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community
- (2016) Kenneth Aldape et al. NEURO-ONCOLOGY
- Association of the Extent of Resection With Survival in Glioblastoma
- (2016) Timothy J. Brown et al. JAMA Oncology
- MR Imaging–Based Analysis of Glioblastoma Multiforme: Estimation ofIDH1Mutation Status
- (2015) K. Yamashita et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Acid Ceramidase in Melanoma
- (2015) Natalia Realini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner
- (2015) Tejas S. Tirodkar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme
- (2015) Wilson Roa et al. JOURNAL OF CLINICAL ONCOLOGY
- Awake craniotomy to maximize glioma resection: methods and technical nuances over a 27-year period
- (2015) Shawn L. Hervey-Jumper et al. JOURNAL OF NEUROSURGERY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
- (2015) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Targeting (cellular) lysosomal acid ceramidase by B13: Design, synthesis and evaluation of novel DMG-B13 ester prodrugs
- (2014) Aiping Bai et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Advanced Magnetic Resonance Imaging of the Physical Processes in Human Glioblastoma
- (2014) Jayashree Kalpathy-Cramer et al. CANCER RESEARCH
- Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline
- (2014) X. Kostaras et al. Current Oncology
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Considerations in prophylaxis for tumor-associated epilepsy: Prevention of status epilepticus and tolerability of newer generation AEDs
- (2013) Thomas Wychowski et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis
- (2013) Kui Zhang et al. Familial Cancer
- A Metabolic Shift Favoring Sphingosine 1-Phosphate at the Expense of Ceramide Controls Glioblastoma Angiogenesis
- (2013) Hazem J. Abuhusain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
- (2013) Kaisorn L. Chaichana et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
- (2013) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity
- (2013) Natalia Realini et al. Scientific Reports
- Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
- (2013) Zhi-Kun Qiu et al. Chinese Journal of Cancer
- Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death
- (2012) Thomas D. Mullen et al. Anti-Cancer Agents in Medicinal Chemistry
- Ceramide synthases at the centre of sphingolipid metabolism and biology
- (2012) Thomas D. Mullen et al. BIOCHEMICAL JOURNAL
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Genetics of adult glioma
- (2012) McKinsey L. Goodenberger et al. Cancer Genetics
- Identification of Cystatin SA as a Novel Inhibitor of Acid Ceramidase
- (2011) Efrat Eliyahu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
- (2011) Albert Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- An extent of resection threshold for newly diagnosed glioblastomas
- (2011) Nader Sanai et al. JOURNAL OF NEUROSURGERY
- Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial
- (2011) Christian Senft et al. LANCET ONCOLOGY
- MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma
- (2011) A. L. Rivera et al. NEURO-ONCOLOGY
- Chain length-specific properties of ceramides
- (2011) Sabine Grösch et al. PROGRESS IN LIPID RESEARCH
- Extent of resection influences outcomes for patients with gliomas
- (2011) N. Sanai et al. REVUE NEUROLOGIQUE
- Serum Autoantibody Profiling Using a Natural Glycoprotein Microarray for the Prognosis of Early Melanoma
- (2010) Yashu Liu et al. JOURNAL OF PROTEOME RESEARCH
- Anti-Tumor Activity of Carmofur Water-Solubilized by Lactic Acid Oligomer-Grafted Pullulan Nanogels
- (2009) Nobuhiko Miyazaki et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas
- (2009) Kaisorn L. Chaichana et al. JOURNAL OF NEUROSURGERY
- Sphingosine-1-Phosphate Regulates Glioblastoma Cell Invasiveness through the Urokinase Plasminogen Activator System and CCN1/Cyr61
- (2009) Nicholas Young et al. MOLECULAR CANCER RESEARCH
- Modulation of invasive properties of CD133(+) glioblastoma stem cells: A role for MT1-MMP in bioactive lysophospholipid signaling
- (2009) Borhane Annabi et al. MOLECULAR CARCINOGENESIS
- Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells
- (2009) S White-Gilbertson et al. ONCOGENE
- Molecular Targeting of Acid Ceramidase: Implications to Cancer Therapy
- (2008) Youssef Zeidan et al. CURRENT DRUG TARGETS
- Autoproteolytic Cleavage and Activation of Human Acid Ceramidase
- (2008) Nataly Shtraizent et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acid Ceramidase Upregulation in Prostate Cancer Cells Confers Resistance to Radiation: AC Inhibition, a Potential Radiosensitizer
- (2008) Ayman EM Mahdy et al. MOLECULAR THERAPY
- Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients
- (2008) Uwe Pichlmeier et al. NEURO-ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now